On CNBC's Mad Money, Jim Cramer said that Gilead Sciences, Inc. (NASDAQ: GILD) has to do an acquisition. Without it, the stock is not going to move higher, because the company has a lot of cash and not a lot of growth.

Cramer thinks Citigroup Inc (NYSE: C) was well prepared for the stress test, and he believes it is a buy at its current price.